These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9548417)
1. Circadian-based effects of AcSDKP, with or without rhG-CSF on hematologic toxicity of chemotherapy in mice. Li XM; Soulard C; Filipski E; Deschamps de Paillette E; Lévi F Eur J Haematol; 1998 Mar; 60(3):181-8. PubMed ID: 9548417 [TBL] [Abstract][Full Text] [Related]
2. Chronopharmacologic aspects of continuous AcSDKP infusion in mice. Li XM; Ezan E; Bindoula G; Soulard C; Liu XH; Deschamps de Paillette E; Lévi F Exp Hematol; 1999 Jan; 27(1):19-27. PubMed ID: 9923440 [TBL] [Abstract][Full Text] [Related]
3. The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo. Aidoudi S; Guigon M; Drouet V; Caen JP; Han ZC Int J Hematol; 1998 Aug; 68(2):145-55. PubMed ID: 9803673 [TBL] [Abstract][Full Text] [Related]
4. Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF. Bogden AE; Moreau JP; Gamba-Vitalo C; Deschamps de Paillette E; Tubiana M; Frindel E; Carde P Int J Cancer; 1998 Mar; 76(1):38-46. PubMed ID: 9533760 [TBL] [Abstract][Full Text] [Related]
6. [Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor]. Shi Y; Han X; He X; Yang J; Liu P Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):462-6. PubMed ID: 12133516 [TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats. Iguchi K; Inoue S; Kumar A Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109 [TBL] [Abstract][Full Text] [Related]
8. In vivo haemoprotective activity of tetrapeptide AcSDKP combined with granulocyte-colony stimulating factor following sublethal irradiation. Watanabe T; Kelsey LS; Yan Y; Brown GS; Jackson JD; Ewel C; Talmadge JE Br J Haematol; 1996 Sep; 94(4):619-27. PubMed ID: 8826883 [TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats. Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401 [TBL] [Abstract][Full Text] [Related]
10. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Kocherlakota P; La Gamma EF Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380 [TBL] [Abstract][Full Text] [Related]
11. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice. Scheding S; Media JE; Nakeff A Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670 [TBL] [Abstract][Full Text] [Related]
13. [Effects of RhG-CSF on apoptosis of HL-60 cell induced by cytarabine]. Wang H; Sun LR; Li L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):996-8. PubMed ID: 16403266 [TBL] [Abstract][Full Text] [Related]
14. rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes. Sica S; Rutella S; Di Mario A; Salutari P; Rumi C; Ortu la Barbera E; Etuk B; Menichella G; D'Onofrio G; Leone G J Hematother; 1996 Aug; 5(4):391-7. PubMed ID: 8877714 [TBL] [Abstract][Full Text] [Related]
15. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation. Watanabe T; Brown GS; Kelsey LS; Yan Y; Jackson JD; Ewel C; Kessinger A; Talmadge JE Exp Hematol; 1996 May; 24(6):713-21. PubMed ID: 8635527 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte colony-stimulating factor accelerates regeneration after T-2 toxin-induced hemopoietic injury and lessens lethality in mice. Ohtani K; Nanya T; Aoyama Y; Matsunami S; Sekijima M; Kawamura O; Ohtsubo K; Ueno Y J Toxicol Sci; 1993 Aug; 18(3):155-66. PubMed ID: 7504113 [TBL] [Abstract][Full Text] [Related]
17. Circadian time dependence of murine tolerance for carboplatin. Boughattas NA; Lévi F; Hecquet B; Lemaigre G; Roulon A; Fournier C; Reinberg A Toxicol Appl Pharmacol; 1988 Nov; 96(2):233-47. PubMed ID: 3057682 [TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on allogeneic bone marrow transplantation in mice. Fukuhara N; Ohnishi N; Mori T; Ozawa A Tokai J Exp Clin Med; 1990 May; 15(2-3):261-2. PubMed ID: 1718058 [TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice. Tanikawa S; Nose M; Aoki Y; Tsuneoka K; Shikita M; Nara N Blood; 1990 Aug; 76(3):445-9. PubMed ID: 1696145 [TBL] [Abstract][Full Text] [Related]
20. A pilot study of continuous infusion Ara-C in combination with rhG-CSF in relapsed childhood acute myeloid leukemia. Laver J; Shearer P; Krance R; Hurwitz CA; Srivastava DK; Weinstein HJ; Mirro J Leuk Lymphoma; 1997 Aug; 26(5-6):589-93. PubMed ID: 9389365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]